October 27, 2016 3:09 AM ET


Company Overview of Catabasis Pharmaceuticals, Inc.

Executive Profile

Kenneth M. Bate MBA

Co-Chairman, Chairman of Audit Committee and Member of Compensation Committee, Catabasis Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 7 Board Members in 7 different organizations across 15 different industries.

See Board Relationships


Mr. Kenneth M. Bate, also known as Ken, MBA was a Principal of JSB-Partners, LP. Mr. Bate has been an independent biotechnology industry consultant since May 2009. He served as the President of Newport Acquisition Corp., a wholly owned subsidiary of NitroMed Inc. He served as the Chief Executive Officer and President of NitroMed Inc., since January 22, 2007 until 2009 and also its Interim Chief Financial Officer from April 11, 2008 to 2009. He is an experienced biotechnology ...

Corporate Headquarters

Building 1400E
Cambridge, Massachusetts 02139

United States

Phone: 617-349-1971
Fax: 617-273-2637

Board Members Memberships

Director, Chairman of Audit Committee and Member of Compensation Committee
Director, Chairman of Compensation Committee and Member of Audit Committee
Independent Director and Member of Audit Committee
Co-Chairman, Chairman of Audit Committee and Member of Compensation Committee
Independent Director


Williams College
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Exercisable Options$4,941
Unexercisable Options$16,036
Total Number of Options$20,977

Total Compensation

Total Annual Cash Compensation$46,875
Total Calculated Compensation$137,722

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Catabasis Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.